Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
ACS Nano
|
March 27, 2026
Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features
Xin Pan, Linwen Lv, Jiayi Wang, et al.
JAMA Network Open
|
May 15, 2024
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt
Jeong Eun Min, Brenda Carolina Guerra-Alejos, Ruyu Yan, et al.
Journal of Pharmaceutical Sciences
|
July 30, 2015
Prolonged Suppression of Neuropathic Pain by Sequential Delivery of Lidocaine and Thalidomide Drugs Using PEGylated Graphene Oxide
Tieying Song, Kunfeng Gu, Wenli Wang, et al.
Cell Death & Disease
|
June 20, 2024
LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer
Ruyu Yan, Dan Liu, Hongjuan Guo, et al.
Nanoscale
|
February 25, 2026
An <sup>124</sup>I-radiolabeled exosome-based treatment platform for enhanced boron neutron capture therapy: precise delivery and real-time PET tracking of boron
Ziteng Chen, Zhijie Wang, Mingxin Yang, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia
Miaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Cancer Biology & Therapy
|
July 5, 2023
VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma
Shuo Yang, Ping Zhou, Lelei Zhang, et al.
Molecular and Cellular Biochemistry
|
March 4, 2025
MiR-3202-DTL signaling axis impedes NSCLC malignancy via regulating the ubiquitination-proteasome degradation of p21
Hongjuan Guo, Qianbin Tang, Yujie Zhao, et al.
Journal of Medicinal Chemistry
|
March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting Parthanatos
Chao Chen, Kaiyuan Liu, Xinlei Wang, et al.
BMJ Open
|
September 1, 2025
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada
Ruyu Yan, Md Belal Hossain, Jeong Eun Min, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
ACS Nano
|
March 27, 2026
Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features
Xin Pan, Linwen Lv, Jiayi Wang, et al.
JAMA Network Open
|
May 15, 2024
Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt
Jeong Eun Min, Brenda Carolina Guerra-Alejos, Ruyu Yan, et al.
Journal of Pharmaceutical Sciences
|
July 30, 2015
Prolonged Suppression of Neuropathic Pain by Sequential Delivery of Lidocaine and Thalidomide Drugs Using PEGylated Graphene Oxide
Tieying Song, Kunfeng Gu, Wenli Wang, et al.
Cell Death & Disease
|
June 20, 2024
LAPTM4B counteracts ferroptosis via suppressing the ubiquitin-proteasome degradation of SLC7A11 in non-small cell lung cancer
Ruyu Yan, Dan Liu, Hongjuan Guo, et al.
Nanoscale
|
February 25, 2026
An <sup>124</sup>I-radiolabeled exosome-based treatment platform for enhanced boron neutron capture therapy: precise delivery and real-time PET tracking of boron
Ziteng Chen, Zhijie Wang, Mingxin Yang, et al.
Journal of Medicinal Chemistry
|
July 19, 2024
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia
Miaomiao Xu, Jingfeng Fu, Yuan Pei, et al.
Cancer Biology & Therapy
|
July 5, 2023
VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma
Shuo Yang, Ping Zhou, Lelei Zhang, et al.
Molecular and Cellular Biochemistry
|
March 4, 2025
MiR-3202-DTL signaling axis impedes NSCLC malignancy via regulating the ubiquitination-proteasome degradation of p21
Hongjuan Guo, Qianbin Tang, Yujie Zhao, et al.
Journal of Medicinal Chemistry
|
March 16, 2026
Discovery of Novel MLKL PROTAC Degraders for the Treatment of Hepatocellular Carcinoma via Promoting Parthanatos
Chao Chen, Kaiyuan Liu, Xinlei Wang, et al.
BMJ Open
|
September 1, 2025
Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada
Ruyu Yan, Md Belal Hossain, Jeong Eun Min, et al.
Page
of 12